FDA Clearance Tracker · P990027-S011
BAUSCH & LOMB TECHNOLAS 217Z ZYOPTIX LASER SYSTEM
Last checked: Nov 20, 2026Latest source record: May 1, 2009 (this decision)Source: openFDAMethods & limitations
Decided
May 1, 2009
Approved
Time to decision
240 days
Received Sep 3, 2008. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P990027-S011
- Device name
- BAUSCH & LOMB TECHNOLAS 217Z ZYOPTIX LASER SYSTEM
- Applicant
- Technolas Perfect Vision GmbH
- Applicant location
- MüNchen
- Received
- Sep 3, 2008
- Decided
- May 1, 2009
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P990027
Device type
- Device type
- Excimer laser system (LZS)
- Device class
- Class III
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE DYNAMIC ROTATIONAL EYE TRACKER WITH IRIS RECOGNITION FOR USE WITH THE BAUSCH & LOMB TECHNOLAS 217Z ZYOPTIX LASER SYSTEM FOR PERSONALIZED VISIONCORRECTION. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME TECHNOLAS 217Z ZYOPTIX LASER SYSTEM FOR PERSONALIZED VISION CORRECTION AND IS INDICATED FOR:1) WAVEFRONT-GUIDED LASER ASSISTED IN-SITU KERATOMILEUSIS (LASIK) TREATMENTS FOR THE REDUCTION ORELIMINATION OF MYOPIA WITH SPHERE UP TO -7.00 D AND CYLINDER UP TO -3.00 D AND MRSE < = 7.50 D ATTHE SPECTACLE PLANE:REDUCTION OR ELIMINATION OF MYOPIA (NEARSIGHTEDNESS) FROM -1.00 D TO -7.00 D WITH LESS THAN -3.00 D ASTIGMATISM;2) REDUCTION OR ELIMINATION OF MYOPIC ASTIGMATISM UP TO -12.00 D MRSE, WITH SPHERE BETWEEN > -7.00 D TO -10.99 D AND CYLINDER BETWEEN 0.00 AND < -3.00 D; AND 4) REDUCTION OR ELIMINATION OF LOW-TO-MODERATE NATURALLY OCCURRING HYPEROPIA UP TO +4.00 D MRSE, WITH SPHERE BETWEEN +1.00 D TO +4.00 D WITH OR WITHOUT REFRACTIVE ASTIGMATISM UP TO+2.00 D AT THE SPECTACLE PLANE.
Source documents
Other decisions for Technolas Perfect Vision GmbH
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- TECHNOLAS TENEO 317 (MODEL 2) Excimer Laser SystemPMA supplement
P990027-S021 · Decided Nov 22, 2023 · 293 days after receipt · Panel Track
Device type: Excimer laser system (LZS) · Ophthalmology
4 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.